Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

FP5

TARGETED GENE VECTOR Sintesi della relazione

Project ID: QLK3-CT-1999-00364
Finanziato nell'ambito di: FP5-LIFE QUALITY
Paese: France

Validation of a Tetracycline conditional expression retroviral vector expressing efficiently and safely a therapeutic gene in glioblastoma in murine models

A tetracycline conditional expression retroviral vector, which has been validated in vitro, is currently being validated for its efficient and safe transduction of a therapeutic gene in models of murine and rat glioblastoma. The vector system is being tested for appropriate propagation and transgene expression within the tumour as well as for any detectable dissemination outside of the tumour. It is also being tested for its therapeutic efficacy, alone or in combination with retroviral vectors transducing other genes of interest.

Contatto

David KLATZMANN, (Professor)
Tel.: +33-142177461
Fax: +33-142177462
E-mail